Concepedia

Yangrui Peng

YP

Statistics

Publications

10

Citations

266

H-Index

10

Active since

2014

Affiliations

East China Normal University(Current)

Southern Medical University

Xian Central Hospital

Yangrui Peng is an author at East China Normal University specializing in pharmacology, drug discovery, and medicine.

ORCID

Publications per year

2014–2024

10

Publications

10

Synthesis and Biological Evaluation of Novel Tetrahydro-β-carboline Derivatives as Antitumor Growth and Metastasis Agents through Inhibiting the Transforming Growth Factor-β Signaling Pathway

Cong Zheng, Yuanzhang Fang, Weiguang Tong et al. · Journal of Medicinal Chemistry · 2014 · 70 citations

, , +9

Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)

Zhaoyong Kang, Li Shen, Yan Li et al. · Chinese Chemical Letters · 2024 · 30 citations

, , +10

Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis

Wangrui Jin, Tao Zhang, Wenbo Zhou et al. · Journal of Medicinal Chemistry · 2022 · 28 citations · Full text

, , +11

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance

Peng He, Juanjuan Feng, Xinting Xia et al. · Journal of Medicinal Chemistry · 2023 · 27 citations

, , +17

Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr<sup>705</sup>/Ser<sup>727</sup> Inhibitory Activity for Gastric Cancer Treatment

Peng He, Ying Miao, Yue Sun et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

, , +8

1–5 of 10